New Inhaled Drug Protects Against Flu

Researchers in Japan have found that one inhaled dose of Daiichi Sankyo Co.Ltd.’s CS8958 (or laninamivir) worked better than Tamiflu to keep mice alive when infected with a normally deadly dose of H5N1 avian influenza.

Treatment Under Development for Autoimmune Diseases

Setpoint Medical, a startup company based in Boston, is developing a nerve stimulator designed to dampen the out-ofcontrol immune system that triggers autoimmune diseases such as inflammatory bowel disease and rheumatoid arthritis.

Teva Launches Lupus Clinical Trial

Teva Pharmaceutical Industries Ltd.is investigating whether its drug Laquinimod, which is in a Phase III clinical trial for treating multiple sclerosis, also is suitable for treating lupus.